These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19305798)

  • 21. Structure-Activity Relationships of Pan-Gα
    Berizzi AE; Bender AM; Lindsley CW; Conn PJ; Sexton PM; Langmead CJ; Christopoulos A
    ACS Chem Neurosci; 2018 Jul; 9(7):1818-1828. PubMed ID: 29683647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy.
    Wakeham MCL; Davie BJ; Chalmers DK; Christopoulos A; Capuano B; Valant C; Scammells PJ
    ACS Chem Neurosci; 2022 Jan; 13(1):97-111. PubMed ID: 34905693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based discovery of selective positive allosteric modulators of antagonists for the M
    Korczynska M; Clark MJ; Valant C; Xu J; Moo EV; Albold S; Weiss DR; Torosyan H; Huang W; Kruse AC; Lyda BR; May LT; Baltos JA; Sexton PM; Kobilka BK; Christopoulos A; Shoichet BK; Sunahara RK
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2419-E2428. PubMed ID: 29453275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allosteric modulators targeting CNS muscarinic receptors.
    Bock A; Schrage R; Mohr K
    Neuropharmacology; 2018 Jul; 136(Pt C):427-437. PubMed ID: 28935216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of allosteric M(1) muscarinic acetylcholine receptor agonists on receptor activation, arrestin 3 recruitment, and receptor downregulation.
    Davis AA; Heilman CJ; Brady AE; Miller NR; Fuerstenau-Sharp M; Hanson BJ; Lindsley CW; Conn PJ; Lah JJ; Levey AI
    ACS Chem Neurosci; 2010 Aug; 1(8):542-551. PubMed ID: 20835371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptor.
    Leach K; Davey AE; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2011 May; 79(5):855-65. PubMed ID: 21300722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
    Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery and Development of Muscarinic Acetylcholine M
    Takai K; Enomoto T
    Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.
    Digby GJ; Shirey JK; Conn PJ
    Mol Biosyst; 2010 Aug; 6(8):1345-54. PubMed ID: 20582339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; El-Fakahany EE; Tucek S
    Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allosteric binding sites on muscarinic acetylcholine receptors.
    Wess J
    Mol Pharmacol; 2005 Dec; 68(6):1506-9. PubMed ID: 16183853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FRET-based detection of M1 muscarinic acetylcholine receptor activation by orthosteric and allosteric agonists.
    Markovic D; Holdich J; Al-Sabah S; Mistry R; Krasel C; Mahaut-Smith MP; Challiss RA
    PLoS One; 2012; 7(1):e29946. PubMed ID: 22272263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor.
    Abdul-Ridha A; Lane JR; Mistry SN; López L; Sexton PM; Scammells PJ; Christopoulos A; Canals M
    J Biol Chem; 2014 Nov; 289(48):33701-11. PubMed ID: 25326383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.
    Franken C; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics.
    Vuckovic Z; Wang J; Pham V; Mobbs JI; Belousoff MJ; Bhattarai A; Burger WAC; Thompson G; Yeasmin M; Nawaratne V; Leach K; van der Westhuizen ET; Khajehali E; Liang YL; Glukhova A; Wootten D; Lindsley CW; Tobin A; Sexton P; Danev R; Valant C; Miao Y; Christopoulos A; Thal DM
    Elife; 2023 May; 12():. PubMed ID: 37248726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and dynamics of the M3 muscarinic acetylcholine receptor.
    Kruse AC; Hu J; Pan AC; Arlow DH; Rosenbaum DM; Rosemond E; Green HF; Liu T; Chae PS; Dror RO; Shaw DE; Weis WI; Wess J; Kobilka BK
    Nature; 2012 Feb; 482(7386):552-6. PubMed ID: 22358844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
    Krejcí A; Tucek S
    Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias.
    van der Westhuizen ET; Choy KHC; Valant C; McKenzie-Nickson S; Bradley SJ; Tobin AB; Sexton PM; Christopoulos A
    Front Pharmacol; 2020; 11():606656. PubMed ID: 33584282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of M2 muscarinic acetylcholine receptor expression and signaling by prolonged exposure to allosteric modulators.
    May LT; Lin Y; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2005 Jan; 312(1):382-90. PubMed ID: 15333678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
    Keov P; Valant C; Devine SM; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
    Mol Pharmacol; 2013 Sep; 84(3):425-37. PubMed ID: 23798605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.